logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Nonsteroidal Anti-inflammatory Drug class drugs

    FiltersReset Filters
    68 results

    • aspirin and extended-release dipyridamole

      (Aspirin and Extended-Release Dipyridamole)
      AvKARE
      Usage: Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients with a history of transient ischemia of the brain or completed ischemic stroke caused by thrombosis.

    • asprin and extended-release dipyridamole

      (ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Aspirin and extended-release dipyridamole capsules are indicated for reducing the risk of stroke in patients with a history of transient ischemia of the brain or completed ischemic stroke due to thrombosis.

    • bromsite

      (bromfenac)
      Sun Pharmaceutical Industries, Inc.
      Usage: BromSite (bromfenac ophthalmic solution) 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.

    • butalbital, aspirin, and caffeine

      (butalbital, aspirin, and caffeine)
      Chartwell RX, LLC
      Usage: Butalbital, aspirin, and caffeine capsules are indicated for relieving tension or muscle contraction headache symptoms. There is insufficient evidence for their efficacy in multiple recurrent headaches. Caution is advised due to the potential for habit formation and abuse associated with butalbital.

    • butalbital, aspirin, caffeine and codeine phosphate

      (BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE)
      Amneal Pharmaceuticals of New York, LLC
      Usage: BUTALBITAL, ASPIRIN, CAFFEINE, and CODEINE PHOSPHATE are indicated for managing tension headaches when non-opioid analgesics are ineffective. Due to addiction risks, it is recommended for patients who cannot tolerate or do not achieve adequate relief from non-opioid treatments and should not be used long-term.

    • cambia

      (diclofenac potassium)
      Assertio Therapeutics, Inc.
      Usage: CAMBIA is indicated for the acute treatment of migraine attacks with or without aura in adults aged 18 and older. It is not intended for prophylactic therapy of migraine or for the treatment of cluster headache.

    • celebrex

      (Celecoxib)
      Viatris Specialty LLC
      Usage: CELEBREX is indicated for the management of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis in patients 2 years and older, ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

    • celecoxib

      (CELECOXIB)
      NIVAGEN PHARMACEUTICALS, INC.
      Usage: Celecoxib capsules are indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

    • celecoxib

      (Celecoxib)
      Chartwell RX, LLC
      Usage: Celecoxib is indicated for the management of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (for patients aged 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.

    • celecoxib

      (Celecoxib)
      Qingdao BAHEAL Pharmaceutical Co., Ltd.
      Usage: Celecoxib capsules are indicated for the management of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.
      • ...